Browse > Article
http://dx.doi.org/10.9799/ksfan.2017.30.2.312

Anti-Inflammatory Properties of Aloe-Emodin in Adipocytes through a TLR4/NF-κB/ERK Signaling Pathway  

Park, Mi-Young (Dept. of Food & Nutrition Education, Graduate School of Education, Soonchunhyang University)
Publication Information
The Korean Journal of Food And Nutrition / v.30, no.2, 2017 , pp. 312-318 More about this Journal
Abstract
Aloe-emodin (AE) is the major bioactive component in aloe and known to exhibit anti-inflammatory activities. However, it has not been elucidated whether its anti-inflammatory potency can contribute to the elimination of obesity. The aim of the current study is to investigate the effect of AE on toll-like receptor 4 (TLR4) pathways in the presence of lipopolysaccharide (LPS) in 3T3-L1 adipocytes. 3T3-L1 adipocytes were treated with AE ($0-20{\mu}M$) for one hour, followed by LPS treatment for 30 min and then, adipokine mRNA expression levels were measured. Next, TLR4-related molecules were measured in LPS-stimulated 3T3-L1 adipocytes. AE significantly decreased the mRNA expression of the tumor necrosis $factor-{\alpha}$ ($TNF-{\alpha}$), interleukin-6 (IL-6), and monocyte chemoattractant protein-1 (MCP-1) in a dose-dependent manner. Moreover, AE suppressed TLR4 mRNA expression. Further study showed that AE could suppress the nuclear $factor-{\kappa}B$ ($NF-{\kappa}B$) and phosphorylation of extracellular receptor-activated kinase (pERK). The results of this study suggest that AE directly inhibits $TLR4/NF-{\kappa}B/ERK$ signaling pathways and decreases the inflammatory response in adipocytes.
Keywords
adipocytes; aloe-emodin; inflammation; toll-like receptor 4 (TLR4);
Citations & Related Records
연도 인용수 순위
  • Reference
1 Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmee E, Cousin B, Sulpice T, Chamontin B, Ferrieres J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R. 2007. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:1761-1772   DOI
2 Chang X, Zhao J, Tian F, Jiang Y, Lu J, Ma J, Zhang X, Jin G, Huang Y, Dong Z, Liu K, Dong Z. 2016. Aloe-emodin suppresses esophageal cancer cell TE1 proliferation by inhibiting AKT and ERK phosphorylation. Oncol Lett 12:2232-2238   DOI
3 Divella R, De Luca R, Abbate I, Naglieri E, Daniele A. 2016. Obesity and cancer: The role of adipose tissue and adipo-cytokines-induced chronic inflammation. J Cancer 7:2346-2359   DOI
4 Doyle SL, O'Neill LA. 2006. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol 72:1102-1113   DOI
5 Fresno M, Alvarez R, Cuesta N. 2011. Toll-like receptors, inflammation, metabolism and obesity. Arch Physiol Biochem 117:151-164   DOI
6 Funahashi T, Nakamura T, Shimomura I, Maeda K, Kuriyama H, Takahashi M, Arita Y, Kihara S, Matsuzawa Y. 1999. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med 38:202-206   DOI
7 Himes RW, Smith CW. 2010. Tlr2 is critical for diet-induced metabolic syndrome in a murine model. FASEB J 24:731-739   DOI
8 Hu B, Zhang H, Meng X, Wang F, Wang P. 2014. Aloe-emodin from rhubarb (Rheum rhabarbarum) inhibits lipopolysaccharideinduced inflammatory responses in RAW264.7 macrophages. J Ethnopharmacol 153:846-853   DOI
9 Johnson GL, Lapadat R. 2002. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298:1911-1912   DOI
10 Kim SJ, Choi Y, Choi YH, Park T. 2012. Obesity activates tolllike receptor-mediated proinflammatory signaling cascades in the adipose tissue of mice. J Nutr Biochem 23:113-122   DOI
11 Kopp A, Buechler C, Bala M, Neumeier M, Scholmerich J, Schaffler A. 2010. Toll-like receptor ligands cause proinflammatory and prodiabetic activation of adipocytes via phosphorylation of extracellular signalregulated kinase and c-Jun N-terminal kinase but not interferon regulatory factor-3. Endocrinology 151:1097-1108   DOI
12 Kshirsagar AD, Panchal PV, Harle UN, Nanda RK, Shaikh HM. 2014. Anti-inflammatory and antiarthritic activity of anthraquinone derivatives in rodents. Int J Inflam 2014:690596
13 Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C(T)) Method. Methods 25:402-408   DOI
14 Schaeffler A, Gross P, Buettner R, Bollheimer C, Buechler C, Neumeier M, Kopp A, Schoelmerich J, Falk W. 2009. Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-kappaB pathway in adipocytes links nutritional signalling with innate immunity. Immunology 126:233-245   DOI
15 Shoelson SE, Herrero L, Naaz A. 2007. Obesity, inflammation, and insulin resistance. Gastroenterology 132:2169-2180   DOI
16 Starr ME, Evers BM, Saito H. 2009. Age-associated increase in cytokine production during systemic inflammation: adipose tissue as a major source of IL-6. J Gerontol A Biol Sci Med Sci 64:723-730
17 Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, Prada PO, Hirabara SM, Schenka AA, Araujo EP, Vassallo J, Curi R, Velloso LA, Saad MJ. 2007. Loss-of-function mutation in Toll-like receptor 4 prevents dietinduced obesity and insulin resistance. Diabetes 56:1986-1998   DOI
18 Yin X, Gong X, Jiang R, Kuang G, Wang B, Zhang L, Xu G, Wan J. 2014. Emodin ameliorated lipopolysaccharide-induced fulminant hepatic failure by blockade of TLR4/MD2 complex expression in D-galactosamine-sensitized mice. Int Immunopharmacol 23:66-72   DOI
19 Andersen DO, Weber ND, Wood SG, Hughes BG, Murray BK, North JA. 1991. In vitro virucidal activity of selected anthraquinones and anthraquinone derivatives. Antiviral Res 16: 185-196   DOI
20 Anderson PD, Mehta NN, Wolfe ML, Hinkle CC, Pruscino L, Comiskey LL, Tabita-Martinez J, Sellers KF, Rickels MR, Ahima RS, Reilly MP. 2007. Innate immunity modulates adipokines in humans. J Clin Endocrinol Metab 92:2272-2279   DOI
21 Arosio B, Gagliano N, Fusaro LM, Parmeggiani L, Tagliabue J, Galetti P, De Castri D, Moscheni C, Annoni G. 2000. Aloe-Emodin quinone pretreatment reduces acute liver injury induced by carbon tetrachloride. Pharmacol Toxicol 87:229-233   DOI
22 Barbarroja N, Lopez-Pedrera R, Mayas MD, Garcia-Fuentes E, Garrido-Sanchez L, Macias-Gonzalez M, El Bekay R, Vidal-Puig A, Tinahones FJ. 2010. The obese healthy paradox: is inflammation the answer? Biochem J 430:141-149   DOI